4 курс / Акушерство и гинекология / Гугушвили_Н_А_Клинико_патогенетическое_обоснование_тактики_ведения

Grissa A., Djrolo F., Moutairou K., Miled A., Khairi H. et al. Growth factorconcentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia // Pregnancy and Childbirth. – 2010. – Vol. 10 – P.7.

138.Gruenwald P. Chronic fetal distress and placental insufficiency // Biol Neonate – 1963. – Vol. 5 – P. 215-221.

139.Gruenwald P. The relation of deprivation to perinatal pathology and late sequels // The Placenta. Lancaster – 1975.

140.Guzman E.R., Vintzileos A.M., Martins M., Benito C., Houlihan C., Hanley M. The efficacy of individual computer heart rate indices in detecting acidemia at birth in growth-restricted fetuses // Obstet Gynecol. – 1996. – Vol. 87 – №6 – P. 969-974.

141.Habek D., Hodek B., Herman R., Jugović D., Cerkez Habek J., Salihagić A. Fetal biophysical profile and cerebro-umbilical ratio in assessment of perinatal outcome in growth-restricted fetuses // Fetal Diagn Ther. – 2003. – Vol. 18 – №1 – P. 12-16.

142.Hadlock F.P., Harrist R.B., Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard // Radiology. – 1991. – Vol. 181 –

№1 – P. 129-133.

143.Hadlock F.P., Harrist R.B., Sharman R.S., Deter R.L., Park S.K. Estimation of fetal weight with the use of head, body and femur measurements—a prospective study // Am J Obstet Gynecol. – 1985 – Vol. 151 – P. 333–337.

144.Harkness U.F., Mari G. Diagnosis and management of intrauterine growth restriction // Clin Perinatol. – 2004. – Vol. 31 – №4 – P.743-764.

145.Hediger M.L., Scholl T.O., Belsky D.H., Ances I. G., Salmon R.W. Patterns of weight gein in adolescent pregnancy: effects on bitht weight and preterm delivery // Obstet Gynecol. – 1989. – Vol. 74 – P. 6-12.

146.Henderson K.G., Shaw T.E., Barrett I.J., Telenius A.H., Wilson R.D., Kalousek D.K. Distribution of mosaicism in human placentae // Hum Genet.

161

– 1996. – Vol. 97 – №5 – P. 650-654.

147.Hendricks C.H. Patterns of fetal and placental growth: the second half of normal pregnancy // Obstet Gynecol. – 1964. – Vol. 24 – P. 357-365.

148.Hernandez-Valencia M., Zarate A., Ochoa R., Fonseca M.E., Amato D., De Jesus Ortiz M. Insulin-like growth factor I, epidermal growth factor and transforming growth factor b expression and their association with intrauterine fetal growth retardation, such as development during human pregnancy // Diabetes, Obesity and Metabolism. – 2001. – Vol. 3 – P. 457– 462.

149.Iyer S., Acharya K.R. Role of placenta growth factor in cardiovascular health // Trends Cardiovasc Med. – 2002. – Vol. 12 – P. 128–134.

150.Jahn A., Razum O., Berle P. Routine screening for intrauterine growth retardation in Germany: low sensitivity and questionable benefit for diagnosed cases // Acta Obstet Gynecol Scand. – 1998. – Vol. 77 – №6 – P. 643-648.

151.Jarvenpaa J., Vuoristo J.T., Savolainen E.R., Ukkola O., Vaskivuo T., Ryynanen M. Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction // Gynecol Endocrinol. – 2007. – Vol. 23 – №6 – P. 351–355.

152.Jelks A., Cifuentes R., Ross M.G. Clinician bias in fundal height measurement // Obstet Gynecol. – 2007. – Vol. 110 – №4 – P. 892-899.

153.Kahn B., Lumey L.H., Zybert P.A., et al. Prospective risk of fetal death in singleton, twin, and triplet gestations: Implications for practice // Obstet Gynecol. – 2003. – Vol. 102. – P. 685-692.

154.Kalousek D.K., Barrett I. Confined placental mosaicism and stillbirth // Pediatr Pathol. – 1994. – Vol. 14 – №1 – P. 151-159.

155.Kanaka-Gantenbein C., Mastorakos G., Chrousos G.P. Endocrine-related causes and consequences of intrauterine growth retardation // Ann N Y Acad Sci. – 2003. – Vol. 997 – P. 150–157.

162

156.Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia // Biol. Reprod. – 2003. – Vol. 69 – P. 1-7.

157.Kiess W., Chernausek S.D., Hokken-Koelega A.C.S. Small for Gestational Age: causes and consequences // Pediatr Adolesc Med. Basel: KARGER, 2009 (13); P. 167.

158.King J.C., Mitzner W., Butterfield A.B., Queenan J.T. Effect of induced oligohydramnios on fetal lung development // Am J Obstet Gynecol. – 1986.

–Vol. 154 – №4 – P. 823-830.

159.Kingdom J., Walker M.,Drewlo S., Keating S. Intrauterine growth restriction: placental basis and implications for clinical practice. // Fetal Deseases: Patogenesis and principles. – 2012.

160.Klauwer D., Blum W.F., Rascher W., Lee P.D., Kiess W. IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns // Acta Paediatr.

–1997. – Vol. 86 – №8 – P. 826-833.

161.Kruger H., Arias-Stella J. The placenta and the newborn infant at high altitudes // Am J Obstet Gynecol. – 1970.

162.Kuizon M., Cheong R.L., Ancheta L.P., Desnacido J.A., Macapinlac M.P., Baens J.C. Effect of anemia and other maternal characteristics on birth weight // Hum Nutr Clin Nutr. – 1985. – Vol. 39 – P. 419-426.

163.Kupferminc M.J. Thrombophilia and pregnancy // Curr Pharm Des. – 2005.

–11 – №6 – P. 735-748.

164.Kupferminc M.J., Fait G., Many A., Gordon D., Eldor A., Lessing J.B. Severe preeclampsia and high frequency of genetic thrombophilic mutations // Obstet Gynecol. – 2000 – Vol. 96 – №1 – P. 45-49.

165.Kupferminc M.J., Many A., Bar-Am A., Lessing J.B., Ascher-Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high

163

prevalence of thrombophilia // BJOG. – 2002 – Vol. 109 – №12 – P. 1373-

1376.

166.Kurjak A., Chervenak F. A. Donald School Textbook of Ultrasound in Obstetrics and Gynecology. 3rd Edition – 2011. – 1022 p.

167.Laskowska M., Laskowska K., Leszczyńska-Gorzelak B., Oleszczuk J. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication // Med Wieku Rozwoj. – 2008 – Vol. 12 – №1 – P. 499-506.

168.Levi S., Kenwez J., Poor intrauterine fetal growth classification based on intauterine echography // Monerva Medica. – 1997. – P. 37-41.

169.Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., et al. Circulating angiogenic factors and the risk of preeclampsia // N Engl J Med. – 2004. – Vol. 350 – P. 672–683.

170.Lubbe WF, Liggins GC. Lupus anticoagulant and pregnancy // Am J Obstet Gynecol. – 1985 – Vol. 153 – №3 – P. 322-327.

171.Lubchenko L., Hansman C., Dressler M., Boyd. E. Intauterine growth as estimated from liveborn birth weight data at 24 to 42 weeks of gestation // Pediatrics. – 1963. – Vol. 32 – P. 793-800.

172.Luke B., Keith L. The contribution of singletons,twins and triplets to low birth weight,infant mortality and handicap in the United States // J Reprod Med – 1992. – Vol. 37 – P. 661 –666.

173.Lunde A., Melve K.K., Gjessing H.K., Skjaerven R., Irgens L.M. Genetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parentoffspring data // Am J Epidemiol. – 2007. – Vol. 165 – №7 – P. 734.

164

174.Luttun A., Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? // J Clin Invest. – 2003 – Vol. 111 – P. 600– 602.

175.Luttun A., Tjwa., Moons L. et al. Revascularization of ischemic tissues by P1GF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Fltl // Nat Med – 2002 – Vol. 8 – P. 831—840.

176.Madazli R., Uludağ S., Ocak V. Doppler assessment of umbilical artery, thoracic aorta and middle cerebral artery in the management of pregnancies with growth restriction // Acta Obstet Gynecol Scand. – 2001 – Vol. 80 –

№8 – P. 702-707.

177.Maglione D., Guerriero V., Viglietto G. et al. Two alternative mRNAs coding for the angiogenic factor, placental growth factor (P1GF), are transcribed from a single gene of chromosome 14 // Oncogene. – 1993 – Vol. 8 – P. 925—931.

178.Malamitsi-Puchner A., Boutsikou T., Economou E., Sarandakou A., Makrakis M., Hassiakos D., Creatsas G. Vascular Endothelial Growth Factor and Placenta Growth Factor in Intrauterine Growth-Restricted Fetuses and Neonates // Mediators of Inflammation. – 2005. – Vol. 2005 –

№5 – P. 293-297.

179.Mandruzzato G.P., Bogatti P., Fischer L., Gigli C. The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery // Ultrasound Obstet Gynecol. – 1991 – Vol. 1 – №3 – P. 192-196.

180.Manning F.A., Baskett T.F., Morrison I., Lange I. Fetal biophysical profile scoring: a prospective study in 1,184 high-risk patients // Am J Obstet Gynecol. – 1981 – Vol. 140 – №3 – P. 289-94.

181.Manning F.A., Hohler C. Intrauterine growth retardation: diagnosis, prognostication, and management based on ultrasound methods // In: Fleischer AC, et al., eds. The principles and practice of ultrasonography in obstetrics and gynecology. 4th ed. Norwalk, Conn.: Appleton & Lange. –

165

1991. – P. 331–348.

182.Manning F.A., Intrauterine Growth Retardetion // Fetal medicine..Principles and practice.Norwalk, CT, Appleton & Lange, 1995.

183.Manning F.A., Morrison I., Lange I.R., Harman C.R., Chamberlain P.F. Fetal assessment based on fetal biophysical profile scoring: experience in 12,620 referred high-risk pregnancies // Perinatal mortality by frequency and etiology. Am J Obstet Gynecol. – 1985. – Vol. 151 – №3 – P. 343-50.

184.Manning. F. The Alpha-Omega Theory: The Prenatal Origins of Postnatal Diseases // OBJ Management. – 2000. – Vol. 20 – P. 30-45.

185.Mari G., Hanif F., Drennan K., Kruger M. Staging of Intrauterine GrowthRestricted Fetuses // J Ultrasound Med. – 2007 – Vol. 26 – P. 1469–1477.

186.Mari G., Hanif F., Kruger M., Cosmi E., Santolaya-Forgas J., Treadwell M.C. Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses // Ultrasound Obstet Gynecol. – 2007. – Vol. 29 – №3 – P. 310-316.

187.Martinelli P., Grandone E., Colaizzo D., Paladini D., Sciannamé N., Margaglione M., Di Minno G. Familial thrombophilia and the occurrence of fetal growth restriction // Haematologica. – 2001. – Vol. 86 – №4 – P. 42831.

188.Maternal physiology of pregnancy: Duration of pregnancy. In: Eastman WJ, Hellman LM, eds. Williams Obstetrics. Appleton century-crofts.– 1966. – 218 p.

189.Mayhew T.M., Charnock-Jones D.S., Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. Part Ш. Changes in Complicated Pregnancies. // Placenta. – 2004. - Vol. 25. – P. 127-139.

190.Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction,

166

hypertension, and proteinuria in preeclampsia // J Clin Invest. – 2003. – Vol.

111 – P. 649–658.

191.McIntire D.D., Bloom S.L., Casey B.M., Leveno K.J. Birth weight in relation to morbidity and mortality among newborn infants // N Engl J Med.

–1999. – Vol. 340 – P. 1234– 1238.

192.McMillen I. C., Robinson J. S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming // Physiological Reviews

–2005. – Vol. 85 – № 2 – P. 571–633.

193.McMillen I. C., Robinson J. S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming // Physiological Reviews.

–2005. – Vol. 85 – № 2 – P. 571–633.

194.Miller J., Turan S., Baschat A. Fetal Growth Restriction // Seminars in Perinatology. – 2008. – Vol. 32 – №4 – P. 274-280.

195.Mondry A., Pengbo L., Loh M., Mongelli M. Z-velocity in screening for intrauterine growth restriction // Ultrasound Obstet Gynecol. – 2005. – Vol. 26 – №6 – P. 634-638.

196.Mongelli M, Yuxin N.G., Biswas A., Chew S. Accuracy of ultrasound dating formulae in the late second-trimester in pregnancies conceived with in-vitro fertilization // Acta Radiol. – 2003. – Vol. 44 – № 4 – P. 452-455.

197.Mongelli M., Ek S., Tambyrajia R. Screening for fetal growth restriction: a mathematical model of the effect of time interval and ultrasound error // Obstet Gynecol. – 1998. – Vol. 92 – №6 – P. 908-12.

198.Mongelli M., Gardosi J. Reduction of false-positive diagnosis of fetal growth restriction by application of customized fetal growth standards // Obstet Gynecol. – 1996. – Vol. 88 – № 5– P. 844–848.

199.Mul T., Mongelli M., Gardosi J. A comparative analysis of second-trimester ultrasound dating formulae in pregnancies conceived with artificial reproductive techniques // Ultrasound Obstet Gynecol. – 1996. – Vol. 8 –

№6 – P. 397-402.

167

200.Murdoch E.M., Sinha A.K., Shanmulinagam S.T. Doppler flow velocimetry in the superior mesenteric artery on the first day of life in preterm infants and the risk of neonatal necrotizing enterocolitis // Pediatrics. – 2006. – Vol. 118 – №5 – P. 1993-2003.

201.Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., Momoeda M., Kozuma S., Taketani Y. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia // Endocrinology. – 2004 – Vol. 145 – P. 4838–4845.

202.Neerhof M.G. Causes of intrauterine growth restriction // Clin Perinatol. – 1995. – Vol. 22 – P. 375–385.

203.Nicolaides K.H., Peters M.T., Vyas S. et al; Relation of rate of urine production to oxygen tension in small-to-gestational-age infants // Am J Obstet Gynecol. – 1990. – Vol. 162 – P. 387.

204.Niermeyer S., Andrade Mollinedo P., Huicho L. Child health and living at high altitude // Arch Dis Child. – 2009. – Vol. 94 – №10 – P. 806-811.

205.Odegård R.A., Vatten L.J., Nilsen S.T., Salvesen K.A., Austgulen R. Preeclampsia and fetal growth // Obstet Gynecol. – 2000. – Vol. 96 – №6 –

P.950-955.

206.Odibo A.O., Riddick C., Pare E., Stamilio D.M., Macones G.A.J. Cerebroplacental Doppler ratio and adverse perinatal outcomes in intrauterine growth restriction: evaluating the impact of using gestational age-specific reference values // Ultrasound Med. – 2005. – Vol. 24 – №9 –

P.1223-1228.

207.Ohlsson R., Falck P., Hellstrom M., Lindahl P., Bostrom H., Franklin G., Ahrlund-Richter L., Pollard J., Soriano P., Betsholtz C. PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta // Developmental Biology. – 1999. – Vol. 212 – P. 124–136.

168

208.Pardey J., Moulden M., Redman C.W. A computer system for the numerical analysis of nonstress tests // Am J Obstet Gynecol. – 2002. – Vol. 186 – №5

– P. 1095-1103.

209.Pardey J., Moulden M., Redman CW. A computer system for the numerical analysis of nonstress tests // Am J Obstet Gynecol. – 2002. – Vol. 186 – №5

– P. 1095-1103.

210.Pedersen J.F. Fetal crown-rump length measurement by ultrasound in normal pregnancy // Br J Obstet Gynaecol. – 1982. – Vol. 89 – №11 – P. 926-30.

211.Peipert J.F., Donnenfeld A.E. Oligohydramnios: a review // Obstet Gynecol Surv. – 1991. – Vol. 46 – №6 – P. 325-39.

212.Phelan J.P., Smith C.V., Broussard P., Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation // J Reprod Med. – 1987. – Vol. 32 – №7 – P. 540-2.

213.Power L.L., Popplewell E.J., Holloway J.A., Diaper N.D., Warner J.O., Jones C.A. Immunoregulatory molecules during pregnancy and at birth //Journal of Reproductive Immunology 2002 – Vol. 56 – P. 19–28.

214.Quinlan R.W., Brumfield C., Martin M., Cruz A.C. Ultrasonic measurement of femur length as a predictor of fetal gestational age // J Reprod Med. – 1982. – Vol. 27 – №7 – P. 392-394.

215.Robinson H.P, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol. – 1975. – Vol. 82 – №9 – P. 702-710.

216.Robinson H.P. Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy // Br Med J. – 1973. – Vol. 4 – №5883 – P. 28-31.

217.Romero R., Nien J.K., Espinoza J., Todem D., Fu W., Chung H et al. A longitudinal study of angiogenic (placental growth factor) and antiangiogenic (soluble endoglin and soluble vascular endothelial growth factor

169

receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate // J Matern Fetal Neonatal Med. – 2008. – Vol. 21 – №1 – P. 9-23.

218.Rosso P., Winick M. Intrauterine growth retardation. A new systematic approach based on the clinical and biochemical characteristics of this condition // J Perinat Med. – 1974 – Vol. 2 – №3 – P. 147-160.

219.Roza S.J., Steegers E.A., Verburg B.O., Jaddoe V.W., Moll H.A., Hofman A., Verhulst F.C., Tiemeier H. What is spared by fetal brain-sparing? Fetal circulatory redistribution and behavioral problems in the general population // Am J Epidemiol. – 2008. – Vol. 168 – №10 – P. 1145-1152.

220.Rumbolz W.L., Mcgoogan L.S. Placental insufficiency and the small undernourished full-term infant // Obstet Gynecol. – 1953. – Vol. 1 – №3 – P. 294-301.

221. Savvidou M.D., Yu C.K., Harland L.C., Hingorani A.D., Nicolaides K.H. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction // Am J Obstet Gynecol. – 2006 – Vol. 195 – №6 P. 1668-1673.

222.Schaap A.H., Wolf H., Bruinse H.W., Smolders-De Haas H., Van Ertbruggen I., Treffers P.E. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants // Obstet Gynecol. – 2001. – Vol. 97 – №6 – P. 954-60.

223.Schiessl B., Innes B.A., Bulmer J.N., Otun H.A., Chadwick T.J., Robson S.C., et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy // Placenta; 2008.

224.Scott J., Urdea M., Quiroga M., Sanchez-Pescador R., Fong N., Selby M., Rutter W.J., Bell G.I. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins // Science. –

170